Responses
Poster Presentation
Rheumatoid arthritis - anti-TNF therapy
THU0213 The Combination Therapy with Dose Escalation and Interval Shortening of Infliximab Makes Better Response to Patients with Rheumatoid Arthritis who Were Loss of Efficacy Against Infliximab
Compose a Response to This Article
Other responses
No responses have been published for this article.